Fostemsavir
Other Antivirals
Sold as Rukobia
- Drug class
- Other Antivirals
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 2
Overview
Fostemsavir is an active pharmaceutical ingredient in the Other Antivirals group (J05AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| EU European Union | EMA | 1 | September 11, 2025 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
EUEuropean Union· EMA
1 product
Uses
1).
How to take
CACanada· Health Canada
1 product
Uses
RUKOBIA (fostemsavir extended release tablets) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced (HTE) adults with multidrug-resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen due to resistance, intolerance or safety considerations.
1 Pediatrics Pediatrics (< 18 years of age): The safety and efficacy of RUKOBIA have not been established in pediatric patients less than 18 years of age. 2 Geriatrics Geriatrics (≥ 65 years of age): Clinical trials of RUKOBIA did not include sufficient numbers of subjects aged 65 and older to determine whether they respond differently from adult patients < 65 years of age.
Drug interactions
Known interactions involving Fostemsavir. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 318. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]European Medicines Agency · EMEA/H/C/005011 · revised September 11, 2025
- [2]Health Canada (DPD) · 02520869 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.